P J Moe|P H Finne - JoVE Visualize

Showing results (61-70 of 99) with videos related to

Pageof 10

Sort By:

Cancer Chemotherapy and Pharmacology|January 1, 1988

PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexateJ D Borsi, O Klepp, P J Moe

Pediatric Research|January 1, 1976

Fatal lactic acidosis in a newborn attributable to a congenital defect of pyruvate dehydrogenaseJ H Strömme, O Borud, P J Moe

Medical and Pediatric Oncology|January 1, 1979

Wilms tumor with extension to the right atriumS Kolmannskog, P J Moe, E Besigye, et al.

Acta Paediatrica Scandinavica|March 1, 1983

Relapse rate after cessation of therapy in childhood leukemia. A material from the five Nordic countriesO J Johansen, M E Eilertsen, P J Moe

Acta Paediatrica (Oslo, Norway : 1992)|April 1, 1996

Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young childrenH Seidel, R Nygaard, I Haave, et al.

Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1984

Cytomegalovirus (CMV) and rubella virus infection during pregnancy. A study of CMV and rubella virus antibodies in 2014 pregnant women and follow-up studies of infants at risk for intrauterine CMV infectionsG Haukenes, P H Finne, E Bertnes, et al.

Pediatric Hematology and Oncology|January 1, 1990

Treatment of refractory aplastic anemia with plasmapheresis: report of a case in childhood with review of the literatureR Austgulen, P J Moe, S Jørstad, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaJ D Borsi, F Wesenberg, T Stokland, et al.

Medical and Pediatric Oncology|January 1, 1990

Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.

Pediatric Hematology and Oncology|January 1, 1990

Rescue after intermediate and high-dose methotrexate: background, rationale, and current practiceJ D Borsi, E Sagen, I Romslo, et al.

Pageof 10

Showing results (61-70 of 99) with videos related to

Sort By:

Pageof 10

Cancer Chemotherapy and Pharmacology|January 1, 1988

PharmCalc: program for the calculation of clinical pharmacokinetic parameters of methotrexateJ D Borsi, O Klepp, P J Moe

Pediatric Research|January 1, 1976

Fatal lactic acidosis in a newborn attributable to a congenital defect of pyruvate dehydrogenaseJ H Strömme, O Borud, P J Moe

Medical and Pediatric Oncology|January 1, 1979

Wilms tumor with extension to the right atriumS Kolmannskog, P J Moe, E Besigye, et al.

Acta Paediatrica Scandinavica|March 1, 1983

Relapse rate after cessation of therapy in childhood leukemia. A material from the five Nordic countriesO J Johansen, M E Eilertsen, P J Moe

Acta Paediatrica (Oslo, Norway : 1992)|April 1, 1996

Magnetic resonance imaging and neurological evaluation after treatment with high-dose methotrexate for acute lymphocytic leukaemia in young childrenH Seidel, R Nygaard, I Haave, et al.

Acta Obstetricia Et Gynecologica Scandinavica|January 1, 1984

Cytomegalovirus (CMV) and rubella virus infection during pregnancy. A study of CMV and rubella virus antibodies in 2014 pregnant women and follow-up studies of infants at risk for intrauterine CMV infectionsG Haukenes, P H Finne, E Bertnes, et al.

Pediatric Hematology and Oncology|January 1, 1990

Treatment of refractory aplastic anemia with plasmapheresis: report of a case in childhood with review of the literatureR Austgulen, P J Moe, S Jørstad, et al.

European Journal of Cancer (Oxford, England : 1990)|January 1, 1991

How much is too much? Folinic acid rescue dose in children with acute lymphoblastic leukaemiaJ D Borsi, F Wesenberg, T Stokland, et al.

Medical and Pediatric Oncology|January 1, 1990

Comparative study on the pharmacokinetics of 7-hydroxy-methotrexate after administration of methotrexate in the dose range of 0.5-33.6 g/m2 to children with acute lymphoblastic leukemiaJ D Borsi, E Sagen, I Romslo, et al.

Pediatric Hematology and Oncology|January 1, 1990

Rescue after intermediate and high-dose methotrexate: background, rationale, and current practiceJ D Borsi, E Sagen, I Romslo, et al.

Pageof 10